Cargando…

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

Detalles Bibliográficos
Autores principales: Bastard, Paul, Lévy, Romain, Henriquez, Soledad, Bodemer, Christine, Szwebel, Tali-Anne, Casanova, Jean-Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990897/
https://www.ncbi.nlm.nih.gov/pubmed/33763778
http://dx.doi.org/10.1007/s10875-021-01023-5
_version_ 1783669145408110592
author Bastard, Paul
Lévy, Romain
Henriquez, Soledad
Bodemer, Christine
Szwebel, Tali-Anne
Casanova, Jean-Laurent
author_facet Bastard, Paul
Lévy, Romain
Henriquez, Soledad
Bodemer, Christine
Szwebel, Tali-Anne
Casanova, Jean-Laurent
author_sort Bastard, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-7990897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79908972021-03-25 Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2 Bastard, Paul Lévy, Romain Henriquez, Soledad Bodemer, Christine Szwebel, Tali-Anne Casanova, Jean-Laurent J Clin Immunol Letter to Editor Springer US 2021-03-25 2021 /pmc/articles/PMC7990897/ /pubmed/33763778 http://dx.doi.org/10.1007/s10875-021-01023-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to Editor
Bastard, Paul
Lévy, Romain
Henriquez, Soledad
Bodemer, Christine
Szwebel, Tali-Anne
Casanova, Jean-Laurent
Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title_full Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title_fullStr Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title_full_unstemmed Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title_short Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
title_sort interferon-β therapy in a patient with incontinentia pigmenti and autoantibodies against type i ifns infected with sars-cov-2
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990897/
https://www.ncbi.nlm.nih.gov/pubmed/33763778
http://dx.doi.org/10.1007/s10875-021-01023-5
work_keys_str_mv AT bastardpaul interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2
AT levyromain interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2
AT henriquezsoledad interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2
AT bodemerchristine interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2
AT szwebeltalianne interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2
AT casanovajeanlaurent interferonbtherapyinapatientwithincontinentiapigmentiandautoantibodiesagainsttypeiifnsinfectedwithsarscov2